Inhibition of HIV-1 replication by simian restriction factors, TRIM5α and APOBEC3G

被引:27
作者
Sakuma, R. [1 ]
Noser, J. A. [1 ]
Ohmine, S. [1 ]
Ikeda, Y. [1 ]
机构
[1] Mayo Clin, Coll Med, Program Mol Med, Rochester, MN 55905 USA
关键词
HIV-1; TRIM5; alpha; APOBEC3G; restriction factor; innate immunity;
D O I
10.1038/sj.gt.3302852
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Old World monkey TRIM5 alpha targets incoming human immunodeficiency virus type 1 ( HIV-1) viral capsid, whereas the apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like ( APOBEC) 3 family hypermutate/degrade viral sequences. Here, we show the potentials of simian TRIM5 alpha and APOBEC3G as therapeutic sequences for AIDS gene therapy. Both rhesus and African green monkey ( agm) TRIM5 alpha efficiently restrict HIV-1 vectors with divergent Gag from different HIV-1 subtypes. Human T cells genetically engineered to express agm-TRIM5 alpha block or delay HIV-1 replication. Although agm-APOBEC3G expression alone only transiently suppresses HIV-1 replication, co-expression of agm-APOBEC3G and agm-TRIM5 alpha successfully block the virus replication for more than 5 weeks.
引用
收藏
页码:185 / 189
页数:5
相关论文
共 37 条
  • [1] PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE
    ADACHI, A
    GENDELMAN, HE
    KOENIG, S
    FOLKS, T
    WILLEY, R
    RABSON, A
    MARTIN, MA
    [J]. JOURNAL OF VIROLOGY, 1986, 59 (02) : 284 - 291
  • [2] TRIM5αrh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages
    Anderson, J
    Akkina, R
    [J]. MOLECULAR THERAPY, 2005, 12 (04) : 687 - 696
  • [3] Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo
    Bai, JR
    Gorantla, S
    Banda, N
    Cagnon, L
    Rossi, J
    Akkina, R
    [J]. MOLECULAR THERAPY, 2000, 1 (03) : 244 - 254
  • [4] Restriction of lentivirus in monkeys
    Besnier, C
    Takeuchi, Y
    Towers, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) : 11920 - 11925
  • [5] A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor
    Bogerd, HP
    Doehle, BP
    Wiegand, HL
    Cullen, BR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) : 3770 - 3774
  • [6] RETRACTED: Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells (Retracted Article. See vol 466, pg 276, 2010)
    Chiu, YL
    Soros, VB
    Kreisberg, JF
    Stopak, K
    Yonemoto, W
    Greene, WC
    [J]. NATURE, 2005, 435 (7038) : 108 - 114
  • [7] AN INFECTIOUS MOLECULAR CLONE OF AN UNUSUAL MACROPHAGE-TROPIC AND HIGHLY CYTOPATHIC STRAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    COLLMAN, R
    BALLIET, JW
    GREGORY, SA
    FRIEDMAN, H
    KOLSON, DL
    NATHANSON, N
    SRINIVASAN, A
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (12) : 7517 - 7521
  • [8] Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5
    Cordelier, P
    Kulkowsky, JW
    Ko, C
    Matskevitch, AA
    McKee, HJ
    Rossi, JJ
    Bouhamdan, M
    Pomerantz, RJ
    Kari, G
    Strayer, DS
    [J]. GENE THERAPY, 2004, 11 (22) : 1627 - 1637
  • [9] Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism
    Cowan, S
    Hatziioannou, T
    Cunningham, T
    Muesing, MA
    Gottlinger, HG
    Bieniasz, PD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) : 11914 - 11919
  • [10] Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition
    Das, AT
    Brummelkamp, TR
    Westerhout, EM
    Vink, M
    Madiredjo, M
    Bernards, R
    Berkhout, B
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (05) : 2601 - 2605